Oct 29, 4:19 PM ET
Eastman Chemical reported third-quarter 2026 sales of $2,385 million, up from $2,202 million, and diluted EPS of $2.19 versus $0.60 a year earlier. The company projects full-year 2026 adjusted EPS of $6.00 to $6.20 and operating cash flow of about $850 million, while operating cash flow in the quarter fell to $290 million from $402 million.
- Q3 2026 sales of $2,385 million, up 8% from $2,202 million, driven mainly by 7% higher selling prices
- Diluted EPS of $2.19 vs. $0.60; adjusted diluted EPS of $1.84 vs. $1.14
- Full-year 2026 outlook: adjusted EPS of $6.00 to $6.20 and operating cash flow of approximately $850 million
- Operating cash flow was $290 million in Q3 2026 vs. $402 million in Q3 2025; the company announced reinstatement of a $375 million U.S. DOE award
Read the filing on SEC.gov ↗
Oct 20, 4:10 PM ET
Eastman Chemical's board adopted amended and restated bylaws on October 16, 2026, effective immediately, changing how stockholders can nominate directors and submit proposals. The company also set the notice window for stockholder director nominations and other business proposals for its 2027 annual meeting, which matters to shareholders who plan to propose items or nominees.
- Board adopted amended and restated bylaws on October 16, 2026, effective immediately
- Advance notice window for 2027 annual meeting nominations and proposals: January 7, 2027 to February 6, 2027
- Proxy access nominations for the 2027 meeting must be delivered October 25, 2026 to November 24, 2026
- Rule 14a-8 stockholder proposal deadline for the 2027 proxy materials remains November 24, 2026
Read the filing on SEC.gov ↗
Jul 30, 4:17 PM ET
Eastman reported second-quarter 2026 sales of $2,513 million, up 10% from $2,287 million a year earlier, with GAAP diluted EPS of $1.59 versus $1.20 and adjusted EPS of $1.97 versus $1.60. The company now expects 2026 operating cash flow to approach $900 million, modestly below its prior expectation of approaching 2025 levels, and projects third-quarter adjusted EPS to approach the $1.97 second-quarter level.
- Second-quarter sales rose 10% to $2,513 million; Chemical Intermediates sales rose 39% while Fibers fell 11%
- Adjusted EBIT rose to $320 million from $275 million; GAAP EBIT was $311 million versus $222 million
- Operating cash flow was $224 million versus $233 million; full-year 2026 operating cash flow now expected to approach $900 million
- Company expects third-quarter 2026 adjusted EPS to approach $1.97 and reaffirmed $125 million to $150 million of cost savings
Read the filing on SEC.gov ↗
Apr 30, 4:17 PM ET
Eastman Chemical reported first-quarter 2026 sales of $2,177 million, down 5% from $2,290 million a year earlier, and adjusted earnings per diluted share of $1.09 versus $1.91. The company projected second-quarter 2026 adjusted EPS of $1.70 to $1.90, which is well above the first quarter but is a sequential range rather than a comparison to the prior year.
- Sales were $2,177 million versus $2,290 million; Fibers fell 22% and Chemical Intermediates fell 9%.
- Adjusted EBIT was $200 million versus $311 million; GAAP EPS was $0.93 versus $1.57.
- Second-quarter 2026 adjusted EPS is projected at $1.70 to $1.90, with about $45 million of planned maintenance costs.
- Net cash used in operating activities was $137 million versus $167 million a year earlier.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
